The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study


Journal article


Anna Santarsieri, Emily Mitchell, My H Pham, Rashesh Sanghvi, Janina Jablonski, Henry Lee-Six, Katherine Sturgess, Pauline Brice, Tobias F Menne, Wendy Osborne, Thomas Creasey, Kirit M Ardeshna, Joanna Baxter, Sarah Behan, Kaljit Bhuller, Stephen Booth, Nikesh D Chavda, Graham P Collins, Dominic J Culligan, Kate Cwynarski, Andrew Davies, Abigail Downing, David Dutton, Michelle Furtado, Eve Gallop-Evans, Andrew Hodson, David Hopkins, Hannah Hsu, Sunil Iyengar, Stephen G Jones, Mamatha Karanth, Kim M Linton, Oliver C Lomas, Nicolas Martinez-Calle, Abhinav Mathur, Pamela McKay, Sateesh K Nagumantry, Elizabeth H Phillips, Neil Phillips, John F Rudge, Nimish K Shah, Gwyneth Stafford, Alex Sternberg, Rachel Trickey, Benjamin J Uttenthal, Natasha Wetherall, Xiao-Yin Zhang, Andrew K McMillan, Nicholas Coleman, Michael R Stratton, Elisa Laurenti, Peter Borchmann, Sven Borchmann, Peter J Campbell, Raheleh Rahbari, George A Follows
Lancet Oncol, 2025


Cite

Cite

APA   Click to copy
Santarsieri, A., Mitchell, E., Pham, M. H., Sanghvi, R., Jablonski, J., Lee-Six, H., … Follows, G. A. (2025). The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study. Lancet Oncol. https://doi.org/10.1016/s1470-2045(24)00598-9


Chicago/Turabian   Click to copy
Santarsieri, Anna, Emily Mitchell, My H Pham, Rashesh Sanghvi, Janina Jablonski, Henry Lee-Six, Katherine Sturgess, et al. “The Genomic and Clinical Consequences of Replacing Procarbazine with Dacarbazine in Escalated BEACOPP for Hodgkin Lymphoma: a Retrospective, Observational Study.” Lancet Oncol (2025).


MLA   Click to copy
Santarsieri, Anna, et al. “The Genomic and Clinical Consequences of Replacing Procarbazine with Dacarbazine in Escalated BEACOPP for Hodgkin Lymphoma: a Retrospective, Observational Study.” Lancet Oncol, 2025, doi:10.1016/s1470-2045(24)00598-9.


BibTeX   Click to copy

@article{anna2025a,
  title = {The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study},
  year = {2025},
  journal = {Lancet Oncol},
  doi = {10.1016/s1470-2045(24)00598-9},
  author = {Santarsieri, Anna and Mitchell, Emily and Pham, My H and Sanghvi, Rashesh and Jablonski, Janina and Lee-Six, Henry and Sturgess, Katherine and Brice, Pauline and Menne, Tobias F and Osborne, Wendy and Creasey, Thomas and Ardeshna, Kirit M and Baxter, Joanna and Behan, Sarah and Bhuller, Kaljit and Booth, Stephen and Chavda, Nikesh D and Collins, Graham P and Culligan, Dominic J and Cwynarski, Kate and Davies, Andrew and Downing, Abigail and Dutton, David and Furtado, Michelle and Gallop-Evans, Eve and Hodson, Andrew and Hopkins, David and Hsu, Hannah and Iyengar, Sunil and Jones, Stephen G and Karanth, Mamatha and Linton, Kim M and Lomas, Oliver C and Martinez-Calle, Nicolas and Mathur, Abhinav and McKay, Pamela and Nagumantry, Sateesh K and Phillips, Elizabeth H and Phillips, Neil and Rudge, John F and Shah, Nimish K and Stafford, Gwyneth and Sternberg, Alex and Trickey, Rachel and Uttenthal, Benjamin J and Wetherall, Natasha and Zhang, Xiao-Yin and McMillan, Andrew K and Coleman, Nicholas and Stratton, Michael R and Laurenti, Elisa and Borchmann, Peter and Borchmann, Sven and Campbell, Peter J and Rahbari, Raheleh and Follows, George A}
}